CAPPS VICKIE L 4

What Happened
Vickie L. Capps, a director of Orthofix Medical Inc. (OFIX), made open-market purchases totaling 5,000 shares across March 9–10, 2026. The trades were: 2,500 shares at $12.48 ($31,200) on 2026-03-09; 100 shares at $12.44 ($1,244) on 2026-03-10; and 2,400 shares at $12.45 ($29,880) on 2026-03-10. These were purchases (code P), indicating acquisition rather than a sale.

Key Details

• Transaction dates and prices:
  • 2026-03-09: 2,500 shares @ $12.48 = $31,200
  • 2026-03-10: 100 shares @ $12.44 = $1,244
  • 2026-03-10: 2,400 shares @ $12.45 = $29,880
• Total acquired: 5,000 shares worth $62,324.
• Shares owned after transactions: 27,585 beneficially owned (this includes 21,934 previously reported deferred stock units and 651 shares acquired under Orthofix's Stock Purchase Plan).
• Footnote: The 651 SPP shares were acquired on 10/31/2025; the SPP is exempt under Rule 16b-3(b)(5) (not subject to Section 16(b) short-swing rules).
• Filing timeliness: Form 4 filed 2026-03-10 for trades on 2026-03-09 and 2026-03-10 — appears timely (within the required reporting window).
• Transaction code: P = Purchase (open market or private purchase).

Context
Director purchases are often viewed as a positive signal because insiders are buying company stock, though they don't prove future performance. These were straightforward open-market purchases (not option exercises, gifts, or sales). No 10% ownership or derivative activity is indicated in this filing.